Literature DB >> 2151342

Stability of gonadorelin and triptorelin in aqueous solution.

V J Helm1, B W Müller.   

Abstract

The influence of pH, temperature, various buffer species at different concentrations, and ionic strength on the stability of gonadorelin and triptorelin in aqueous solution has been studied using stability-indicating high-performance liquid chromatographic methods. The degradation behavior of both peptides is similar. The maximum stability of both peptides was shown to be at an approximate pH of 5.0. Acetate has the most favorable effect on stability, while phosphate causes higher degradation. Varying the concentration of acetate buffer does not affect the degradation behavior of the peptides. A higher phosphate concentration in buffer solutions causes higher degradation, however. The ionic strength of buffer solutions has no significant influence on stability. Solutions of gonadorelin and triptorelin, respectively, buffered with acetate (0.1 M, pH 5.0) with 3% (w/v) mannitol as an additive show a predicted t90% of 9.0 years and 7.7 years at 20 degrees C, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2151342     DOI: 10.1023/a:1015981704133

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Letter: Effect of storage on LHRH.

Authors:  W C Dermody; J R Reel
Journal:  N Engl J Med       Date:  1976-07-15       Impact factor: 91.245

Review 2.  Clinical applications of GnRH analogs.

Authors:  G Forti
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

3.  The stability of synthetic gonadotropin-releasing hormone in solution.

Authors:  P M Hahn; D A Van Vugt; R L Reid
Journal:  Fertil Steril       Date:  1987-07       Impact factor: 7.329

4.  Effect of storage of LH-RH.

Authors:  J Sandow; E Vogl; W Bogie
Journal:  N Engl J Med       Date:  1977-04-14       Impact factor: 91.245

Review 5.  Gonadotrophin releasing hormone: from physiology to pharmacology.

Authors:  R N Clayton
Journal:  Clin Endocrinol (Oxf)       Date:  1987-03       Impact factor: 3.478

Review 6.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

7.  Thermal stability of a long-acting analogue of luteinizing hormone releasing hormone (D-trp6-pro9-NEt-LHRH).

Authors:  J Winterer; D Chatterji; F Comite; M H Decker; D L Loriaux; J F Gallelli; G B Cutler
Journal:  Contraception       Date:  1983-02       Impact factor: 3.375

8.  Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D-amino acid substitutions in position 6.

Authors:  D H Coy; J A Vilchez-Martinez; E J Coy; A V Schally
Journal:  J Med Chem       Date:  1976-03       Impact factor: 7.446

9.  Long-term stability of aqueous solutions of luteinizing hormone-releasing hormone assessed by an in vitro bioassay and liquid chromatography.

Authors:  Y F Shi; R J Sherins; D Brightwell; J F Gallelli; D C Chatterji
Journal:  J Pharm Sci       Date:  1984-06       Impact factor: 3.534

Review 10.  Gonadotropin-releasing hormone: physiological and therapeutic aspects, agonists and antagonists.

Authors:  R J Santen; J P Bourguignon
Journal:  Horm Res       Date:  1987
View more
  2 in total

1.  Data analysis of kinetic modelling used in drug stability studies: isothermal versus nonisothermal assays.

Authors:  Alexis Oliva; Matías Llabrés; José B Fariña
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

2.  Is stability prediction possible for protein drugs? Denaturation kinetics of beta-galactosidase in solution.

Authors:  S Yoshioka; Y Aso; K Izutsu; S Kojima
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.